Evidence map›Paper›PMID 33384692›Full record

ArticleFrontiers in immunology2020

Anti-FIM and Anti-FHA Antibodies Inhibit

Issaka Yougbare, Adam McTague, Liwei He, Christopher H Choy, Jin Su, Beata Gajewska, Ali Azizi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Issaka YougbareImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Adam McTagueImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Liwei HeImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Christopher H ChoyImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Jin SuImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Beata GajewskaImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Ali AziziImmunology platform, Analytical Sciences North America, Sanofi Pasteur, Toronto, ON, Canada.
Sanofi (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pertussis vaccination is highly recommended for infants, children, and pregnant women. Despite a high coverage of vaccination, pertussis continues to be of public health concern as a re-emerging infectious disease. The mechanism by which vaccine-elicited anti-pertussis antibodies mediate direct bactericidal effects is poorly understood. In this study, we showed that the interaction of

Indexed as

A549 CellsAdhesins, BacterialAnimalsAntibodies, MonoclonalAntigens, BacterialBacterial AdhesionBordetella pertussisCytokinesFimbriae ProteinsGuinea PigsHost-Pathogen InteractionsHumansImmunity, HumoralImmunogenicity, VaccineInflammation MediatorsMicrobial ViabilityAdhesins, BacterialAntibodies, MonoclonalAntigens, BacterialCytokinesfilamentous hemagglutinin adhesin, Bordetella pertussisFimbriae ProteinsInflammation MediatorsPertussis VaccineVirulence Factors, Bordetellaaggregationanti-pertussis antibodiesbacterial growth inhibitioncytokinesepithelial inflammation

Identifiers

PMID33384692
PMCPMC7770163
OpenAlexW3117493653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.